{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:39:26Z","timestamp":1792035566380,"version":"4.4.0"},"reference-count":117,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>Polycystic ovary syndrome (PCOS) is the most common endocrine metabolic disorder found in women of reproductive age and is characterized by both metabolic and reproductive dysfunction. Women with PCOS commonly have insulin resistance, increased susceptibility to type 2 diabetes mellitus, dyslipidemia, hyperinsulinemia, increased cardiovascular risk, hepatic steatosis, infertility, and an overall reduction in physical and psychological well-being. Several previous studies have shown a causal association between PCOS and hepatic disorders, such as chronic liver disease (CLD) and nonalcoholic fatty liver disease (NAFLD), where PCOS was identified as contributing to the hepatic features. Whilst it is recognized that PCOS may contribute to hepatic dysfunction, there is also evidence that the liver may contribute to the features of PCOS. The purpose of this review is to discuss the current understanding regarding hepatic involvement in PCOS pathophysiology, the inflammatory markers and hepatokines involved in the development of PCOS, and the role of genetics in the occurrence of PCOS. This review illustrates that PCOS and NAFLD are both common disorders and that there is both genetic and metabolic linkage between the disorders. As such, whilst PCOS may contribute to NAFLD development, the converse may also be the case, with a potential bidirectional relationship between PCOS and liver disease.<\/jats:p>","DOI":"10.3390\/biom15010051","type":"journal-article","created":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T10:32:26Z","timestamp":1735813946000},"page":"51","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["The Role of the Liver in the Pathophysiology of PCOS: A Literature Review"],"prefix":"10.3390","volume":"15","author":[{"given":"Abrar","family":"Alhermi","sequence":"first","affiliation":[{"name":"School of Medicine, Royal College of Surgeons of Ireland, Busaiteen, Adliya P.O. Box 15503, Bahrain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1763-1172","authenticated-orcid":false,"given":"Heather","family":"Perks","sequence":"additional","affiliation":[{"name":"School of Medicine, Royal College of Surgeons of Ireland, Busaiteen, Adliya P.O. Box 15503, Bahrain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varsha","family":"Nigi","sequence":"additional","affiliation":[{"name":"School of Medicine, Royal College of Surgeons of Ireland, Busaiteen, Adliya P.O. Box 15503, Bahrain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noor","family":"Altahoo","sequence":"additional","affiliation":[{"name":"School of Medicine, Royal College of Surgeons of Ireland, Busaiteen, Adliya P.O. Box 15503, Bahrain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5887-7257","authenticated-orcid":false,"given":"Stephen L.","family":"Atkin","sequence":"additional","affiliation":[{"name":"Research Department, Royal College of Surgeons of Ireland, Busaiteen, Adliya P.O. Box 15503, Bahrain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5762-3917","authenticated-orcid":false,"given":"Alexandra E.","family":"Butler","sequence":"additional","affiliation":[{"name":"Research Department, Royal College of Surgeons of Ireland, Busaiteen, Adliya P.O. Box 15503, Bahrain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,1,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/AOG.0000000000002698","article-title":"Polycystic Ovary Syndrome","volume":"132","author":"Azziz","year":"2018","journal-title":"Obstet. Gynecol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.ncrna.2024.01.002","article-title":"Biomarker potential of competing endogenous RNA networks in Polycystic Ovary Syndrome (PCOS)","volume":"9","author":"Heidarzadehpilehrood","year":"2024","journal-title":"Noncoding RNA Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"261","DOI":"10.4103\/jhrs.JHRS_95_18","article-title":"The Prevalence of Polycystic Ovary Syndrome: A Brief Systematic Review","volume":"13","author":"Deswal","year":"2020","journal-title":"J. Hum. Reprod. Sci."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrendo.2018.24","article-title":"Polycystic ovary syndrome: Definition, aetiology, diagnosis and treatment","volume":"14","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1210\/js.2019-00078","article-title":"Polycystic Ovary Syndrome: Pathophysiology, Presentation, and Treatment with Emphasis on Adolescent Girls","volume":"3","author":"Witchel","year":"2019","journal-title":"J. Endocr. Soc."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"16057","DOI":"10.1038\/nrdp.2016.57","article-title":"Polycystic ovary syndrome","volume":"2","author":"Azziz","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4239\/wjd.v13.i3.129","article-title":"Markers of insulin resistance in Polycystic ovary syndrome women: An update","volume":"13","author":"Amisi","year":"2022","journal-title":"World J. Diabetes"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Chen, Y., Ma, L., Ge, Z., Pan, Y., and Xie, L. (2022). Key Genes Associated with Non-Alcoholic Fatty Liver Disease and Polycystic Ovary Syndrome. Front. Mol. Biosci., 9.","DOI":"10.3389\/fmolb.2022.888194"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Harada, M. (2022). Pathophysiology of polycystic ovary syndrome revisited: Current understanding and perspectives regarding future research. Reprod. Med. Biol., 21.","DOI":"10.1002\/rmb2.12487"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.metabol.2017.09.016","article-title":"Polycystic ovarian syndrome (PCOS): Long-term metabolic consequences","volume":"86","author":"Anagnostis","year":"2018","journal-title":"Metab.-Clin. Exp."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Christ, J.P., and Cedars, M.I. (2023). Current Guidelines for Diagnosing PCOS. Diagnostics, 13.","DOI":"10.3390\/diagnostics13061113"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Farhadi-Azar, M., Behboudi-Gandevani, S., Rahmati, M., Mahboobifard, F., Khalili Pouya, E., Ramezani Tehrani, F., and Azizi, F. (2022). The Prevalence of Polycystic Ovary Syndrome, Its Phenotypes and Cardio-Metabolic Features in a Community Sample of Iranian Population: Tehran Lipid and Glucose Study. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.825528"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.fertnstert.2023.07.025","article-title":"Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome","volume":"120","author":"Teede","year":"2023","journal-title":"Fertil. Steril."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e1071","DOI":"10.1210\/clinem\/dgaa839","article-title":"Update on PCOS: Consequences, Challenges, and Guiding Treatment","volume":"106","author":"Hoeger","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1038\/s41591-019-0666-1","article-title":"Prenatal androgen exposure and transgenerational susceptibility to polycystic ovary syndrome","volume":"25","author":"Risal","year":"2019","journal-title":"Nat. Med."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Butler, A.E., Ramachandran, V., Sathyapalan, T., David, R., Gooderham, N.J., Benurwar, M., Dargham, S.R., Hayat, S., Hani Najafi-Shoushtari, S., and Atkin, S.L. (2020). microRNA Expression in Women With and Without Polycystic Ovarian Syndrome Matched for Body Mass Index. Front. Endocrinol., 11.","DOI":"10.3389\/fendo.2020.00206"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Nasser, J.S., Altahoo, N., Almosawi, S., Alhermi, A., and Butler, A.E. (2024). The Role of MicroRNA, Long Non-Coding RNA and Circular RNA in the Pathogenesis of Polycystic Ovary Syndrome: A Literature Review. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25020903"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.fertnstert.2010.11.036","article-title":"Circulating inflammatory markers in polycystic ovary syndrome: A systematic review and metaanalysis","volume":"95","year":"2011","journal-title":"Fertil. Steril."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/cld.1061","article-title":"Global Epidemiology of Chronic Liver Disease","volume":"17","author":"Cheemerla","year":"2021","journal-title":"Clin. Liver Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e490","DOI":"10.1002\/edm2.490","article-title":"Association Between Insulin Resistance Indices and Liver Function Parameters Among Women with Polycystic Ovary Syndrome","volume":"7","author":"Mousavi","year":"2024","journal-title":"Endocrinol. Diabetes Metab."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"8351","DOI":"10.3748\/wjg.v20.i26.8351","article-title":"Nonalcoholic fatty liver disease and polycystic ovary syndrome","volume":"20","author":"Vassilatou","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1038\/sj.ki.5001834","article-title":"Lipotoxicity","volume":"70","author":"Weinberg","year":"2006","journal-title":"Kidney Int."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/OGX.0000000000000661","article-title":"Polycystic Ovary Syndrome: Impact of Lipotoxicity on Metabolic and Reproductive Health","volume":"74","author":"Brennan","year":"2019","journal-title":"Obstet. Gynecol. Surv."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"5438","DOI":"10.1210\/en.2010-0551","article-title":"High-fat diet causes lipotoxicity responses in cumulus-oocyte complexes and decreased fertilization rates","volume":"151","author":"Wu","year":"2010","journal-title":"Endocrinology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.ando.2022.11.004","article-title":"Polycystic ovary syndrome and adipose tissue","volume":"84","author":"Lemaitre","year":"2023","journal-title":"Ann. D\u2019endocrinol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.coemr.2020.02.013","article-title":"Endocrine\u2013metabolic dysfunction in polycystic ovary syndrome: An evolutionary perspective","volume":"12","author":"Dumesic","year":"2020","journal-title":"Curr. Opin. Endocr. Metab. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1210\/jc.2017-00947","article-title":"AKR1C3-Mediated Adipose Androgen Generation Drives Lipotoxicity in Women with Polycystic Ovary Syndrome","volume":"102","author":"Kempegowda","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Butler, A.E., Moin, A.S.M., Reiner, \u017d., Sathyapalan, T., Jamialahmadi, T., Sahebkar, A., and Atkin, S.L. (2023). HDL-Associated Proteins in Subjects with Polycystic Ovary Syndrome: A Proteomic Study. Cells, 12.","DOI":"10.3390\/cells12060855"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Liu, D., Gao, X., Pan, X.-F., Zhou, T., Zhu, C., Li, F., Fan, J.-G., Targher, G., and Zhao, J. (2023). The hepato-ovarian axis: Genetic evidence for a causal association between non-alcoholic fatty liver disease and polycystic ovary syndrome. BMC Med., 21.","DOI":"10.1186\/s12916-023-02775-0"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Von-Hafe, M., Borges-Canha, M., Vale, C., Leite, A.R., S\u00e9rgio Neves, J., Carvalho, D., and Leite-Moreira, A. (2022). Nonalcoholic Fatty Liver Disease and Endocrine Axes\u2014A Scoping Review. Metabolites, 12.","DOI":"10.3390\/metabo12040298"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.amjmed.2006.06.029","article-title":"Polycystic Ovary Syndrome: Diagnosis and Treatment","volume":"120","author":"Setji","year":"2007","journal-title":"Am. J. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.1210\/jc.2003-030219","article-title":"Glucose-to-Insulin Ratio Rather than Sex Hormone-Binding Globulin and Adiponectin Levels Is the Best Predictor of Insulin Resistance in Nonobese Women with Polycystic Ovary Syndrome","volume":"88","author":"Ducluzeau","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/nrgastro.2009.33","article-title":"Endocrine and liver interaction: The role of endocrine pathways in NASH","volume":"6","author":"Loria","year":"2009","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_34","first-page":"511","article-title":"Shifting Our Focus from NASH to MASH","volume":"19","author":"Lichtenstein","year":"2023","journal-title":"Gastroenterol. Hepatol."},{"key":"ref_35","first-page":"697","article-title":"Examining the Nomenclature Change from NAFLD and NASH to MASLD and MASH","volume":"19","author":"Rinella","year":"2023","journal-title":"Gastroenterol. Hepatol."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Gao, Y., Zou, Y., Wu, G., and Zheng, L. (2023). Oxidative stress and mitochondrial dysfunction of granulosa cells in polycystic ovarian syndrome. Front. Med., 10.","DOI":"10.3389\/fmed.2023.1193749"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/humupd\/dms059","article-title":"Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): A systematic review and meta-analysis","volume":"19","author":"Murri","year":"2013","journal-title":"Hum. Reprod. Update"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"8589318","DOI":"10.1155\/2016\/8589318","article-title":"Roles of Oxidative Stress in Polycystic Ovary Syndrome and Cancers","volume":"2016","author":"Zuo","year":"2016","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Awonuga, A.O., Camp, O.G., and Abu-Soud, H.M. (2023). A review of nitric oxide and oxidative stress in typical ovulatory women and in the pathogenesis of ovulatory dysfunction in PCOS. Reprod. Biol. Endocrinol., 21.","DOI":"10.1186\/s12958-023-01159-6"},{"key":"ref_40","first-page":"643","article-title":"Circulating levels of apoptotic markers and oxidative stress parameters in women with polycystic ovary syndrome: A case-controlled descriptive study","volume":"22","author":"Uyanikoglu","year":"2017","journal-title":"Biomarkers"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4103\/0974-1208.101020","article-title":"Assessment of oocyte quality in polycystic ovarian syndrome and endometriosis by spindle imaging and reactive oxygen species levels in follicular fluid and its relationship with IVF-ET outcome","volume":"5","author":"Rajani","year":"2012","journal-title":"J. Hum. Reprod. Sci."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Li, W., Liu, C., Yang, Q., Zhou, Y., Liu, M., and Shan, H. (2022). Oxidative stress and antioxidant imbalance in ovulation disorder in patients with polycystic ovary syndrome. Front. Nutr., 9.","DOI":"10.3389\/fnut.2022.1018674"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"86","DOI":"10.4103\/ijpvm.IJPVM_576_17","article-title":"Oxidative Stress and Polycystic Ovary Syndrome: A Brief Review","volume":"10","author":"Mohammadi","year":"2019","journal-title":"Int. J. Prev. Med."},{"key":"ref_44","first-page":"4579831","article-title":"Role of Oxidative Stress in Obese and Nonobese PCOS Patients","volume":"2022","author":"Demir","year":"2022","journal-title":"Int. J. Clin. Pract."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Nandakumar, M., Sathyapalan, T., Butler, A.E., and Atkin, S.L. (2023). Oxidative Stress Markers and Heat Shock Proteins in Non-Obese Women with Polycystic Ovary Syndrome Are not Elevated and Show No Correlation with Vitamin D. Biomedicines, 11.","DOI":"10.3390\/biomedicines11072044"},{"key":"ref_46","first-page":"149","article-title":"The effect of resveratrol on oxidative stress in the liver and serum of a rat model of polycystic ovary syndrome: An experimental study","volume":"16","author":"Ghowsi","year":"2018","journal-title":"Int. J. Reprod. Biomed."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Dabravolski, S.A., Nikiforov, N.G., Eid, A.H., Nedosugova, L.V., Starodubova, A.V., Popkova, T.V., Bezsonov, E.E., and Orekhov, A.N. (2021). Mitochondrial Dysfunction and Chronic Inflammation in Polycystic Ovary Syndrome. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22083923"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1590\/1806-9282.20200860","article-title":"The importance of inflammation markers in polycystic ovary syndrome","volume":"67","year":"2021","journal-title":"Rev. Assoc. Med. Bras."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Rudnicka, E., Suchta, K., Grymowicz, M., Calik-Ksepka, A., Smolarczyk, K., Duszewska, A.M., Smolarczyk, R., and Meczekalski, B. (2021). Chronic Low Grade Inflammation in Pathogenesis of PCOS. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22073789"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"90","DOI":"10.17305\/bjbms.2007.3100","article-title":"C-reactive protein in obese PCOS women and the effect of metformin therapy","volume":"7","year":"2007","journal-title":"Bosn. J. Basic Med. Sci."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Cui, P., Hu, W., Ma, T., Hu, M., Tong, X., Zhang, F., Shi, J., Xu, X., Li, X., and Shao, L.R. (2021). Long-term androgen excess induces insulin resistance and non-alcoholic fatty liver disease in PCOS-like rats. J. Steroid Biochem. Mol. Biol., 208.","DOI":"10.1016\/j.jsbmb.2021.105829"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/s12967-023-04116-4","article-title":"The interplay between androgens and the immune response in polycystic ovary syndrome","volume":"21","author":"Shabbir","year":"2023","journal-title":"J. Transl. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00404-020-05951-2","article-title":"Association of metabolic and inflammatory markers with polycystic ovarian syndrome (PCOS): An update","volume":"303","year":"2021","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_54","first-page":"425","article-title":"Anti-Inflammatory Effects of Curcumin on Insulin Resistance Index, Levels of Interleukin-6, C-Reactive Protein, and Liver Histology in Polycystic Ovary Syndrome-Induced Rats","volume":"19","author":"Mohammadi","year":"2017","journal-title":"Cell J."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Peng, Z., Sun, Y., Lv, X., Zhang, H., Liu, C., and Dai, S. (2016). Interleukin-6 Levels in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0157389"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1089\/gtmb.2014.0151","article-title":"Tumor necrosis factor-alpha and polycystic ovarian syndrome: A clinical, biochemical, and molecular genetic study","volume":"18","author":"Thathapudi","year":"2014","journal-title":"Genet. Test. Mol. Biomark."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Krishnan, A., Muthusami, S., Periyasamy, L., Stanley, J.A., Gopalakrishnan, V., and Ramachandran, I. (2020). Effect of DHT-Induced Hyperandrogenism on the Pro-Inflammatory Cytokines in a Rat Model of Polycystic Ovary Morphology. Medicina, 56.","DOI":"10.3390\/medicina56030100"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/JOE-21-0143","article-title":"AGEs-related dysfunctions in PCOS: Evidence from animal and clinical research","volume":"251","author":"Tatone","year":"2021","journal-title":"J. Endocrinol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/bs.acc.2018.12.003","article-title":"Chapter Three\u2014Clinical implications of fetuin-A","volume":"Volume 89","author":"Makowski","year":"2019","journal-title":"Advances in Clinical Chemistry"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Liu, S., Hu, W., He, Y., Li, L., Liu, H., Gao, L., Yang, G., and Liao, X. (2020). Serum Fetuin-A levels are increased and associated with insulin resistance in women with polycystic ovary syndrome. BMC Endocr. Disord., 20.","DOI":"10.1186\/s12902-020-0538-1"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Ramanjaneya, M., Bensila, M., Bettahi, I., Jerobin, J., Samra, T.A., Aye, M.M., Alkasem, M., Siveen, K.S., Sathyapalan, T., and Skarulis, M. (2020). Dynamic Changes in Circulating Endocrine FGF19 Subfamily and Fetuin-A in Response to Intralipid and Insulin Infusions in Healthy and PCOS Women. Front. Endocrinol., 11.","DOI":"10.3389\/fendo.2020.568500"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"116","DOI":"10.5653\/cerm.2018.45.3.116","article-title":"Associations of serum fetuin-A and oxidative stress parameters with polycystic ovary syndrome","volume":"45","author":"Sak","year":"2018","journal-title":"Clin. Exp. Reprod. Med."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Zhan, K., Liu, R., Tong, H., Gao, S., Yang, G., Hossain, A., Li, T., and He, W. (2020). Fetuin B overexpression suppresses proliferation, migration, and invasion in prostate cancer by inhibiting the PI3K\/AKT signaling pathway. Biomed. Pharmacother., 131.","DOI":"10.1016\/j.biopha.2020.110689"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1530\/EC-19-0243","article-title":"Increased serum fetuin-B concentration is associated with HOMA-\u03b2 and indices of liver steatosis in women with polycystic ovary syndrome: A pilot study","volume":"8","author":"Adamska","year":"2019","journal-title":"Endocr. Connect."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.cmet.2015.09.023","article-title":"Fetuin B Is a Secreted Hepatocyte Factor Linking Steatosis to Impaired Glucose Metabolism","volume":"22","author":"Meex","year":"2015","journal-title":"Cell Metab."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2483435","DOI":"10.1155\/2020\/2483435","article-title":"Elevated Circulating Fetuin-B Levels Are Associated with Insulin Resistance and Reduced by GLP-1RA in Newly Diagnosed PCOS Women","volume":"2020","author":"Mokou","year":"2020","journal-title":"Mediat. Inflamm."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"819","DOI":"10.3109\/09513590.2010.487587","article-title":"Serum fibroblast growth factor 21 levels in polycystic ovary syndrome","volume":"26","author":"Gorar","year":"2010","journal-title":"Gynecol. Endocrinol."},{"key":"ref_68","first-page":"803","article-title":"Diagnostic Value of Bile Acids and Fibroblast Growth Factor 21 in Women with Polycystic Ovary Syndrome","volume":"3","author":"Yoost","year":"2022","journal-title":"Womens Health Rep."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1530\/EC-21-0082","article-title":"Association between FGF19, FGF21 and lipocalin-2, and diabetes progression in PCOS","volume":"10","author":"Cheng","year":"2021","journal-title":"Endocr. Connect."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Giannouli, A., Stefanaki, C., Kouskoutis, C., Konidari, M., Mani, I., Konidari, K., Markantonis, S.L., Mantzou, A., Dourakis, S.P., and Deligeoroglou, E. (2023). Hepatokine Profile in Adolescents with Polycystic Ovary Syndrome: A Case\u2013Control Study. J. Clin. Med., 12.","DOI":"10.3390\/jcm12175744"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3109\/00365513.2014.900821","article-title":"Fibroblast growth factor 21 and its relation to metabolic parameters in women with polycystic ovary syndrome","volume":"74","author":"Sahin","year":"2014","journal-title":"Scand. J. Clin. Lab. Investig."},{"key":"ref_72","first-page":"5175","article-title":"Metabolic role of hepassocin in polycystic ovary syndrome","volume":"27","author":"Omma","year":"2023","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1080\/01443615.2021.1887112","article-title":"Elevated circulating Selenoprotein P levels in patients with polycystic ovary syndrome","volume":"42","author":"Temur","year":"2022","journal-title":"J. Obstet. Gynaecol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.cmet.2010.09.015","article-title":"A Liver-Derived Secretory Protein, Selenoprotein P, Causes Insulin Resistance","volume":"12","author":"Misu","year":"2010","journal-title":"Cell Metab."},{"key":"ref_75","first-page":"e30351","article-title":"Insulin Resistance in Polycystic Ovarian Syndrome","volume":"14","author":"Purwar","year":"2022","journal-title":"Cureus"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Dogru, T., Kirik, A., Gurel, H., Rizvi, A.A., Rizzo, M., and Sonmez, A. (2021). The Evolving Role of Fetuin-A in Nonalcoholic Fatty Liver Disease: An Overview from Liver to the Heart. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22126627"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Pan, X., Kaminga, A.C., Chen, J., Luo, M., and Luo, J. (2020). Fetuin-A and Fetuin-B in Non-Alcoholic Fatty Liver Disease: A Meta-Analysis and Meta-Regression. Int. J. Environ. Res. Public Health, 17.","DOI":"10.3390\/ijerph17082735"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1053\/j.gastro.2010.04.054","article-title":"Increased Fibroblast Growth Factor 21 in Obesity and Nonalcoholic Fatty Liver Disease","volume":"139","author":"Dushay","year":"2010","journal-title":"Gastroenterology"},{"key":"ref_79","first-page":"36","article-title":"Fibroblast growth factor 21 levels and liver inflammatory biomarkers in obese subjects after weight loss","volume":"18","author":"Cantero","year":"2022","journal-title":"Arch. Med. Sci."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Kim, T.H., Hong, D.-G., and Yang, Y.M. (2021). Hepatokines and Non-Alcoholic Fatty Liver Disease: Linking Liver Pathophysiology to Metabolism. Biomedicines, 9.","DOI":"10.3390\/biomedicines9121903"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Caviglia, G.P., Rosso, C., Armandi, A., Gaggini, M., Carli, F., Abate, M.L., Olivero, A., Ribaldone, D.G., Saracco, G.M., and Gastaldelli, A. (2020). Interplay between Oxidative Stress and Metabolic Derangements in Non-Alcoholic Fatty Liver Disease: The Role of Selenoprotein P. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21228838"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s13048-023-01223-0","article-title":"Integrated bioinformatics analysis elucidates granulosa cell whole-transcriptome landscape of PCOS in China","volume":"16","author":"Li","year":"2023","journal-title":"J. Ovarian Res."},{"key":"ref_83","first-page":"148","article-title":"Effects of PCSK9 inhibitors on metabolic-associated fatty liver disease: A short review","volume":"18","author":"Jakielska","year":"2023","journal-title":"Prz. Gastroenterol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1007\/s43032-022-00930-1","article-title":"Serum-Derived Exosomal microRNAs in Lipid Metabolism in Polycystic Ovary Syndrome","volume":"29","author":"Hong","year":"2022","journal-title":"Reprod. Sci."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"2166483","DOI":"10.1080\/09513590.2023.2166483","article-title":"miR-761-hepcidin\/Gpx4 pathway contribute to unexplained liver dysfunction in polycystic ovary syndrome by regulating liver iron overload and ferroptosis","volume":"39","author":"Zheng","year":"2023","journal-title":"Gynecol. Endocrinol."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Qu, X., and Donnelly, R. (2020). Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21218191"},{"key":"ref_87","first-page":"545","article-title":"Sex Hormone-Binding Globulin Reduction in Metabolic Disorders May Play a Role in NAFLD Development","volume":"158","author":"Hernandez","year":"2017","journal-title":"Endocrinology"},{"key":"ref_88","first-page":"1004","article-title":"Sex hormone binding globulin, but not testosterone, is associated with the metabolic syndrome in overweight and obese women with polycystic ovary syndrome","volume":"36","author":"Moran","year":"2013","journal-title":"J. Endocrinol. Investig."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1210\/jc.2005-2774","article-title":"Nonalcoholic steatohepatitis and nonalcoholic Fatty liver disease in young women with polycystic ovary syndrome","volume":"91","author":"Setji","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/ncpendmet0637","article-title":"The reproductive phenotype in polycystic ovary syndrome","volume":"3","author":"Chang","year":"2007","journal-title":"Nat. Clin. Pract. Endocrinol. Metab."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Salva-Pastor, N., Ch\u00e1vez-Tapia, N.C., Uribe, M., and Nu\u00f1o-L\u00e1mbarri, N. (2019). Understanding the association of polycystic ovary syndrome and non-alcoholic fatty liver disease. J. Steroid Biochem. Mol. Biol., 194.","DOI":"10.1016\/j.jsbmb.2019.105445"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.bpobgyn.2016.03.003","article-title":"Hepatic manifestations of women with polycystic ovary syndrome","volume":"37","author":"Chen","year":"2016","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1210\/jc.2002-020557","article-title":"The biological variation of testosterone and sex hormone-binding globulin (SHBG) in polycystic ovarian syndrome: Implications for SHBG as a surrogate marker of insulin resistance","volume":"88","author":"Jayagopal","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1210\/clinem\/dgaa574","article-title":"Sex Hormone Relations to Histologic Severity of Pediatric Nonalcoholic Fatty Liver Disease","volume":"105","author":"Mueller","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Kumarendran, B., O\u2019Reilly, M.W., Manolopoulos, K.N., Toulis, K.A., Gokhale, K.M., Sitch, A.J., Wijeyaratne, C.N., Coomarasamy, A., Arlt, W., and Nirantharakumar, K. (2018). Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database. PLoS Med., 15.","DOI":"10.1371\/journal.pmed.1002542"},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Song, M.J., and Choi, J.Y. (2022). Androgen dysfunction in non-alcoholic fatty liver disease: Role of sex hormone binding globulin. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.1053709"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1038\/s41419-020-03261-8","article-title":"Hepatocyte cannabinoid 1 receptor nullification alleviates toxin-induced liver damage via NF-\u03baB signaling","volume":"11","author":"Kim","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1111\/cen.12951","article-title":"Serum levels of TSP-1, NF-\u03baB and TGF-\u03b21 in polycystic ovarian syndrome (PCOS) patients in northern China suggest PCOS is associated with chronic inflammation","volume":"83","author":"Liu","year":"2015","journal-title":"Clin. Endocrinol."},{"key":"ref_99","first-page":"232975","article-title":"Cannabinoid receptor 1 gene polymorphisms and nonalcoholic Fatty liver disease in women with polycystic ovary syndrome and in healthy controls","volume":"2014","author":"Laczmanski","year":"2014","journal-title":"Int. J. Endocrinol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3109\/09513590.2014.946899","article-title":"Selected CNR1 polymorphisms and hyperandrogenemia as well as fat mass and fat distribution in women with polycystic ovary syndrome","volume":"31","author":"Kuliczkowska","year":"2015","journal-title":"Gynecol. Endocrinol."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Recuero, A.M., Gomes, L.G., Maciel, G.A.R., de Mello Malta, F., Salles, A.P.M., Vezozzo, D.C.P., Baracat, E.C., Pinho, J.R.R., Carrilho, F.J., and Stefano, J.T. (2022). NAFLD in Polycystic Ovary Syndrome: Association with PNPLA3 and Metabolic Features. Biomedicines, 10.","DOI":"10.3390\/biomedicines10112719"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"353","DOI":"10.21037\/hbsn.2019.10.35","article-title":"PNPLA3 and nonalcoholic fatty liver disease: Towards personalized medicine for fatty liver","volume":"9","author":"Yuan","year":"2020","journal-title":"Hepatobiliary Surg. Nutr."},{"key":"ref_103","first-page":"32","article-title":"Association of follistatin and cytochrome p450 side-chain cleavage enzyme with polycystic ovarian syndrome","volume":"16","author":"Nazir","year":"2022","journal-title":"Int. J. Health Sci."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1210\/jc.2003-031640","article-title":"Large-scale analysis of the relationship between CYP11A promoter variation, polycystic ovarian syndrome, and serum testosterone","volume":"89","author":"Gaasenbeek","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s12944-020-01366-9","article-title":"Association of CYP19A1 and CYP1A2 genetic polymorphisms with type 2 diabetes mellitus risk in the Chinese Han population","volume":"19","author":"Yang","year":"2020","journal-title":"Lipids Health Dis."},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Della Torre, S. (2020). Non-alcoholic Fatty Liver Disease as a Canonical Example of Metabolic Inflammatory-Based Liver Disease Showing a Sex-Specific Prevalence: Relevance of Estrogen Signaling. Front. Endocrinol., 11.","DOI":"10.3389\/fendo.2020.572490"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.2147\/DMSO.S449494","article-title":"A Review: Cytochrome P450 in Alcoholic and Non-Alcoholic Fatty Liver Disease","volume":"17","author":"Jiang","year":"2024","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Pei, K., Gui, T., Kan, D., Feng, H., Jin, Y., Yang, Y., Zhang, Q., Du, Z., Gai, Z., and Wu, J. (2020). An Overview of Lipid Metabolism and Nonalcoholic Fatty Liver Disease. Biomed Res. Int., 2020.","DOI":"10.1155\/2020\/4020249"},{"key":"ref_109","first-page":"960","article-title":"Genotyping of CYP21, Linked Chromosome 6p Markers, and a Sex-Specific Gene in Neonatal Screening for Congenital Adrenal Hyperplasia1","volume":"84","author":"Fitness","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jsbmb.2005.06.035","article-title":"Novel mutation of the CYP17 gene in two unrelated patients with combined 17alpha-hydroxylase\/17,20-lyase deficiency: Demonstration of absent enzyme activity by expressing the mutant CYP17 gene and by three-dimensional modeling","volume":"97","author":"Patocs","year":"2005","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1124\/dmd.111.042697","article-title":"Ontogeny of novel cytochrome P450 gene isoforms during postnatal liver maturation in mice","volume":"40","author":"Cui","year":"2012","journal-title":"Drug Metab. Dispos."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.trsl.2020.02.003","article-title":"Altered circadian clock as a novel therapeutic target for constant darkness-induced insulin resistance and hyperandrogenism of polycystic ovary syndrome","volume":"219","author":"Li","year":"2020","journal-title":"Transl. Res."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.cmet.2013.12.016","article-title":"Circadian clocks and feeding time regulate the oscillations and levels of hepatic triglycerides","volume":"19","author":"Adamovich","year":"2014","journal-title":"Cell Metab."},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Shimba, S., Ogawa, T., Hitosugi, S., Ichihashi, Y., Nakadaira, Y., Kobayashi, M., Tezuka, M., Kosuge, Y., Ishige, K., and Ito, Y. (2011). Deficient of a clock gene, brain and muscle Arnt-like protein-1 (BMAL1), induces dyslipidemia and ectopic fat formation. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0025231"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.cmet.2010.10.005","article-title":"PER2 controls lipid metabolism by direct regulation of PPAR\u03b3","volume":"12","author":"Grimaldi","year":"2010","journal-title":"Cell Metab."},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Sun, L., Tian, H., Xue, S., Ye, H., Xue, X., Wang, R., Liu, Y., Zhang, C., Chen, Q., and Gao, S. (2021). Circadian Clock Genes REV-ERBs Inhibits Granulosa Cells Apoptosis by Regulating Mitochondrial Biogenesis and Autophagy in Polycystic Ovary Syndrome. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.658112"},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Griffett, K., Bedia-Diaz, G., Elgendy, B., and Burris, T.P. (2020). REV-ERB agonism improves liver pathology in a mouse model of NASH. PLoS ONE, 15.","DOI":"10.1101\/2020.06.29.177378"}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/15\/1\/51\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T15:23:31Z","timestamp":1759850611000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/15\/1\/51"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,2]]},"references-count":117,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["biom15010051"],"URL":"https:\/\/doi.org\/10.3390\/biom15010051","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,2]]}}}